title: In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.
abstract: The in vivo dopaminergic neurotoxic properties of 45 MPTP and MPP+ analogues and related compounds were examined by an intrastriatal microdialysis assay in conscious rats. MPP(+)-like toxicity, as evidenced by the irreversible effects on DA release and enhancement of lactate formation, was observed with a variety of structural types although no compound was more toxic than MPP+. The following global structure-toxicity relationships could be derived: (1) only permanently charged compounds showed neurotoxic effects; (2) with the exception of amino groups, hydrophilic substituents abolished toxicity; (3) activity was enhanced by lipophilic groups although increased steric bulk around the nitrogen atom tended to decrease activity; (4) nonaromatic, quaternary systems (methiodide of MPTP, guanidinium derivatives) were only weakly toxic; and (5) certain bi- and tricyclic systems, including putative metabolites of potential endogenous MPTP-like compounds, were weakly toxic. The lack of toxic effects following perfusions with DA itself confirmed that MPTP dopaminergic neurotoxicity is not likely to be mediated by the MPP(+)-induced release of DA. With some interesting exceptions, these in vivo data correlate reasonably well with in vitro data on the nerve terminal uptake properties and the inhibitory effects on mitochondrial respiration of these compounds.
authors.affiliation: Department of Medicinal Chemistry, University Center for Pharmacy, Groningen, The Netherlands.
authors.forename: H
authors.initials: H
authors.lastname: Rollema
authors.forename: E A
authors.initials: EA
authors.lastname: Johnson
authors.forename: R G
authors.initials: RG
authors.lastname: Booth
authors.forename: P
authors.initials: P
authors.lastname: Caldera
authors.forename: P
authors.initials: P
authors.lastname: Lampen
authors.forename: S K
authors.initials: SK
authors.lastname: Youngster
authors.forename: A J
authors.initials: AJ
authors.lastname: Trevor
authors.forename: N
authors.initials: N
authors.lastname: Naiman
authors.forename: N
authors.initials: N
authors.lastname: Castagnoli
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000031:analogs & derivatives / Q000494:pharmacology; D015655:1-Methyl-4-phenylpyridinium / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D003956:Dialysis; D004298:Dopamine / Q000378:metabolism; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D020267:MPTP Poisoning; D008297:Male; D015394:Molecular Structure; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship
chemical_list: D007773:Lactates; D019344:Lactic Acid; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine